RFG
AUPH icon

RFP Financial Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

RFP Financial Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,000
Closed -$8.99K – 866
2023
Q4 		$8.99K Hold
1,000
– – ﹤0.01% 432
2023
Q3 		$7.77K Hold
1,000
– – ﹤0.01% 427
2023
Q2 		$9.68K Buy
+1,000
New +$10.4K ﹤0.01% 424
2023
Q1 		– Sell
-1,000
Closed -$4.32K – 748
2022
Q4 		$4.32K Buy
+1,000
New +$5.8K ﹤0.01% 549

Other funds holding AUPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RFP Financial Group's AUPH Position: Q1 2024 in Review

RFP Financial Group sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2024, closing a stake of 1,000 shares — an estimated $8.99K sold.

RFP Financial Group first reported a position in AUPH in Q4 2022 and held it in 4 quarters. The position peaked at $9.68K in Q2 2023. 179 funds tracked by Wall St. Rank hold AUPH as of Q1 2024.

  • RFP Financial Group reported no remaining Aurinia Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • RFP Financial Group sold 1,000 Aurinia Pharmaceuticals shares in Q1 2024, an estimated $8.99K.
  • RFP Financial Group first reported a position in Aurinia Pharmaceuticals in Q4 2022 and held it in 4 quarters.
  • RFP Financial Group's Aurinia Pharmaceuticals position peaked at $9.68K in Q2 2023.
  • 179 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2024.

Based on RFP Financial Group's 13F filing for Q1 2024, filed 9 May 2024.